{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:41:31Z","timestamp":1788871291182,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":770,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Fonds de la Recherche en Sant\u00e9 du Qu\u00e9bec","award":["9967"],"award-info":[{"award-number":["9967"]}]},{"name":"Fonds de la Recherche en Sant\u00e9 du Qu\u00e9bec","award":["24460"],"award-info":[{"award-number":["24460"]}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bbmt.2012.12.002","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T03:02:10Z","timestamp":1354849330000},"page":"468-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Excess of Veno-Occlusive Disease in a Randomized Clinical Trial on a Higher Trigger for Red Blood Cell Transfusion after Bone Marrow Transplantation: A Canadian Blood and Marrow Transplant Group Trial"],"prefix":"10.1016","volume":"19","author":[{"given":"Nancy","family":"Robitaille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomir","family":"Alexandrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Cortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk R.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2012.12.002_bib1","first-page":"265","article-title":"Early infectious complications in autologous bone marrow transplantation: a review of 219 patients","volume":"18","author":"Mossad","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.12.002_bib2","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1182\/blood.V88.10.4058.bloodjournal88104058","article-title":"Mortality hazard functions as related to neutropenia at different times after marrow transplantation","volume":"88","author":"Offner","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib3","first-page":"355","article-title":"Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma","volume":"18","author":"Nosanchuk","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.12.002_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0140-6736(78)91570-2","article-title":"Controlled study of hypertransfusion during remission induction in childhood acute lymphocytic leukaemia","volume":"2","author":"Toogood","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2012.12.002_bib5","first-page":"439","article-title":"Myeloid stem cell kinetics in children hypertransfused during remission induction of acute lymphoblastic leukemia","volume":"8","author":"de Montpellier","year":"1982","journal-title":"Blood Cells"},{"key":"10.1016\/j.bbmt.2012.12.002_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2141.1977.tb00579.x","article-title":"Effect of hypertransfusion on granulopoiesis in bone marrow depression: studies in the irradiated mouse","volume":"35","author":"Firkin","year":"1977","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2012.12.002_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood.V56.1.52.52","article-title":"Effect of hypertransfusion on bone marrow regeneration in sublethally irradiated mice. I. Enhanced granulopoietic recovery","volume":"56","author":"Smith","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood.V56.1.58.58","article-title":"Effect of hypertransfusion on bone marrow regeneration in sublethally irradiated mice. II. Enhanced recovery of megakaryocytes and platelets","volume":"56","author":"Smith","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1182\/blood.V96.1.80","article-title":"A\u00a0randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation","volume":"96","author":"Bishop","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/sj.bmt.1702872","article-title":"Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone\u00a0marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose","volume":"27","author":"Keever-Taylor","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.12.002_bib11","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood.V97.11.3405","article-title":"Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors","volume":"97","author":"Przepiorka","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1200\/JCO.2004.06.102","volume":"22","author":"Ringden","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.12.002_bib13","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V84.5.1680.1680","article-title":"Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation","volume":"84","author":"Schriber","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib14","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V97.8.2514","article-title":"Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants","volume":"97","author":"Volpi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib15","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/j.1537-2995.2008.01876.x","article-title":"Reduced hemoglobin on day of\u00a0peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation","volume":"48","author":"Kasbia","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2012.12.002_bib16","first-page":"141A","article-title":"Effect of pre-transplant hemoglobin and platelet counts on transfusion requirements and survival in allogeneic transplantation","volume":"45","author":"Tinmouth","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2012.12.002_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1537-2995.2003.00339.x","article-title":"RBC transfusion requirements after allogeneic marrow transplantation: impact of the before-transplant Hb level on transfusion and early survival","volume":"43","author":"Xenocostas","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2012.12.002_bib18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/sj.bjc.6600247","article-title":"The level of haemoglobin in anaemic cancer patients correlates positively with quality of life","volume":"86","author":"Lind","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2012.12.002_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1745-6215-12-207","article-title":"Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trial","volume":"12","author":"Tay","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.bbmt.2012.12.002_bib20","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa066240","article-title":"Transfusion strategies for patients in pediatric intensive care units","volume":"356","author":"Lacroix","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2012.12.002_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jpeds.2006.05.011","article-title":"The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants","volume":"149","author":"Kirpalani","year":"2006","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.bbmt.2012.12.002_bib22","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A\u00a0multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group","volume":"340","author":"Hebert","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2012.12.002_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0268-960X(03)00002-X","article-title":"Veno-occlusive disease: cytokines, genetics, and haemostasis","volume":"17","author":"Coppell","year":"2003","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2012.12.002_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00062752-200311000-00010","article-title":"Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment","volume":"10","author":"Wadleigh","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2012.12.002_bib25","first-page":"3599","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2012.12.002_bib27","first-page":"11","article-title":"Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation","volume":"3","author":"Sanders","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.12.002_bib28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.1993.11.2.304","article-title":"Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens","volume":"11","author":"Radich","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.12.002_bib29","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","article-title":"Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation","volume":"102","author":"Wadleigh","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.12.002_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.bmt.1703025","article-title":"Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection","volume":"27","author":"Moscardo","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.12.002_bib32","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00007890-199112000-00015","article-title":"Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation","volume":"52","author":"Soiffer","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.12.002_bib33","first-page":"1831","article-title":"A\u00a0randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies","volume":"26","author":"Ringden","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2012.12.002_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.bmt.1704209","article-title":"Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results","volume":"32","author":"Dalle","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.12.002_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/157488608783333899","article-title":"Busulfan use in hematopoietic stem cell transplantation: pharmacology, dose adjustment, safety and efficacy in adults and children","volume":"3","author":"Krivoy","year":"2008","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.bbmt.2012.12.002_bib36","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V79.10.2784.2784","article-title":"Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan\/cyclophosphamide","volume":"79","author":"Essell","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib37","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1182\/blood.V92.12.4568","article-title":"Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation","volume":"92","author":"Hagglund","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib38","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1200\/JCO.1991.9.7.1224","article-title":"Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation","volume":"9","author":"Nevill","year":"1991","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2012.12.002_bib39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.tp.0000167758.63247.f4","article-title":"Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children","volume":"80","author":"Lapierre","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.12.002_bib40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/00007890-199512000-00009","article-title":"Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?","volume":"60","author":"Klaesson","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2012.12.002_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1083-8791(98)90006-4","article-title":"Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation","volume":"4","author":"Sullivan","year":"1998","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.12.002_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-139-1-200307010-00007","article-title":"Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial","volume":"139","author":"Cordonnier","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2012.12.002_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.12.002_bib44","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1542\/peds.2004-1884","article-title":"Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants","volume":"115","author":"Bell","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbmt.2012.12.002_bib45","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.bmt.1703014","article-title":"Avoiding hepatic veno-occlusive disease: what do we know and where are we going?","volume":"27","author":"Bearman","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.12.002_bib46","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1537-2995.2010.03026.x","article-title":"The effects of long-term storage of human red blood cells on the glutathione synthesis rate and steady-state concentration","volume":"51","author":"Whillier","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2012.12.002_bib47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-3476(98)70226-4","article-title":"Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study","volume":"133","author":"Beck","year":"1998","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.bbmt.2012.12.002_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0955-3886(00)00049-7","article-title":"Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction","volume":"23","author":"Wadhwa","year":"2000","journal-title":"Transfus Sci"},{"key":"10.1016\/j.bbmt.2012.12.002_bib49","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1537-2995.2009.02196.x","article-title":"Stored red blood cell supernatant facilitates thrombin generation","volume":"49","author":"Sweeney","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2012.12.002_bib50","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2009-10-245001","article-title":"Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation","volume":"115","author":"Hod","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.12.002_bib51","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/j.1537-2995.2009.02319.x","article-title":"Length of storage and in\u00a0vitro immunomodulation induced by prestorage leukoreduced red blood cells","volume":"49","author":"Karam","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2012.12.002_bib52","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1537-2995.2009.02251.x","article-title":"Rejuvenation treatment of stored red blood cells reverses storage-induced adhesion to vascular endothelial cells","volume":"49","author":"Koshkaryev","year":"2009","journal-title":"Transfusion"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911201138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911201138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:45:55Z","timestamp":1761057955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387911201138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S108387911201138X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.12.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969540.793468997","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717969540.793470452","asserted-by":"object"}]},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excess of Veno-Occlusive Disease in a Randomized Clinical Trial on a Higher Trigger for Red Blood Cell Transfusion after Bone Marrow Transplantation: A Canadian Blood and Marrow Transplant Group Trial","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}